NO20050163L - Mikrokapsler for den forsinkede og kontrollerte frigivelse av perindopril - Google Patents

Mikrokapsler for den forsinkede og kontrollerte frigivelse av perindopril

Info

Publication number
NO20050163L
NO20050163L NO20050163A NO20050163A NO20050163L NO 20050163 L NO20050163 L NO 20050163L NO 20050163 A NO20050163 A NO 20050163A NO 20050163 A NO20050163 A NO 20050163A NO 20050163 L NO20050163 L NO 20050163L
Authority
NO
Norway
Prior art keywords
perindopril
microcapsules
controlled release
delayed
administration
Prior art date
Application number
NO20050163A
Other languages
English (en)
Inventor
Remi Meyrueix
Bruno Huet De Barochez
Patrick Wuthrich
Valerie Legrand
Catherine Castan
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20050163L publication Critical patent/NO20050163L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører mikrokapsler som tillater forsinket og konttollert fiigivelse av perindopril, eller av et farmasøytisk akseptabelt salt derav, for administtasjon ved den orale rute.
NO20050163A 2002-06-24 2005-01-12 Mikrokapsler for den forsinkede og kontrollerte frigivelse av perindopril NO20050163L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207778A FR2841140B1 (fr) 2002-06-24 2002-06-24 Microcapsules pour la liberation retardee et controlee du perindopril
PCT/FR2003/001931 WO2004000286A1 (fr) 2002-06-24 2003-06-24 Microcapsules pour la liberation retardee et controlee du perindopril

Publications (1)

Publication Number Publication Date
NO20050163L true NO20050163L (no) 2005-01-12

Family

ID=29719985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050163A NO20050163L (no) 2002-06-24 2005-01-12 Mikrokapsler for den forsinkede og kontrollerte frigivelse av perindopril

Country Status (37)

Country Link
US (1) US20060165808A1 (no)
EP (1) EP1515704B1 (no)
JP (1) JP4723243B2 (no)
KR (1) KR100722082B1 (no)
CN (1) CN100345541C (no)
AP (1) AP2029A (no)
AR (1) AR040461A1 (no)
AT (1) ATE429214T1 (no)
AU (1) AU2003260620B2 (no)
BR (1) BR0312026A (no)
CA (1) CA2491172C (no)
CR (1) CR7648A (no)
CY (1) CY1109154T1 (no)
DE (1) DE60327318D1 (no)
DK (1) DK1515704T3 (no)
EA (1) EA007571B1 (no)
EC (1) ECSP055570A (no)
ES (1) ES2326218T3 (no)
FR (1) FR2841140B1 (no)
GE (1) GEP20074212B (no)
HR (1) HRP20050055B1 (no)
IL (1) IL165896A0 (no)
IS (1) IS2679B (no)
MA (1) MA27262A1 (no)
ME (1) ME00452B (no)
MX (1) MXPA05000086A (no)
NO (1) NO20050163L (no)
NZ (1) NZ537408A (no)
OA (1) OA12875A (no)
PL (1) PL374377A1 (no)
PT (1) PT1515704E (no)
RS (1) RS50914B (no)
SI (1) SI1515704T1 (no)
TN (1) TNSN04259A1 (no)
UA (1) UA81121C2 (no)
WO (1) WO2004000286A1 (no)
ZA (1) ZA200410333B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
FR2897865B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FI125776B2 (fi) 2008-06-27 2023-07-28 Metsaeliitto Osuuskunta Menetelmä puulevyn käsittelemiseksi
CN106983731A (zh) * 2017-04-20 2017-07-28 上药东英（江苏）药业有限公司 一种培哚普利控释片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2247186A1 (de) * 1972-09-26 1974-03-28 Bayer Ag Antimykotisches mittel
JPS55129219A (en) * 1979-03-29 1980-10-06 Asahi Chem Ind Co Ltd Slow-releasing preparation
EP1442745A1 (en) * 1993-10-07 2004-08-04 Euro-Celtique Orally administrable opioid formulations having extended duration of effect
DE19724696A1 (de) * 1997-06-12 1998-12-24 Hexal Ag Pharmazeutische Zubereitung mit drei Pelletarten
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
JPH11171769A (ja) * 1997-12-05 1999-06-29 Nichiko Pharmaceutical Co Ltd ３−イソブチリル−２−イソプロピルピラゾロ〔１，５−ａ〕ピリジンの徐放性製剤及びその製法
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
WO2001087284A2 (en) * 2000-05-11 2001-11-22 Pharmacia Corporation Aldosterone antagonist composition for release during aldosterone acrophase
EP1492511B3 (fr) * 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
CN1189150C (zh) * 2002-11-07 2005-02-16 张凤英 祛斑美白面膜
CN100389300C (zh) * 2004-01-17 2008-05-21 湖北清江水布垭工程建设公司 大坝面板挠度或坝体内部变形监测方法及装置

Also Published As

Publication number Publication date
AR040461A1 (es) 2005-04-06
RS112904A (sr) 2007-02-05
EP1515704B1 (fr) 2009-04-22
JP4723243B2 (ja) 2011-07-13
FR2841140A1 (fr) 2003-12-26
OA12875A (en) 2006-09-15
HRP20050055B1 (hr) 2013-11-08
US20060165808A1 (en) 2006-07-27
TNSN04259A1 (fr) 2007-03-12
JP2005533079A (ja) 2005-11-04
WO2004000286A1 (fr) 2003-12-31
BR0312026A (pt) 2005-03-22
ZA200410333B (en) 2006-07-26
DE60327318D1 (de) 2009-06-04
HRP20050055A2 (en) 2005-02-28
ES2326218T3 (es) 2009-10-05
AP2004003193A0 (en) 2004-12-31
EA200500030A1 (ru) 2005-06-30
FR2841140B1 (fr) 2004-10-01
IL165896A0 (en) 2006-01-15
CR7648A (es) 2005-07-18
ME00452B (me) 2011-10-10
EP1515704A1 (fr) 2005-03-23
CY1109154T1 (el) 2014-07-02
NZ537408A (en) 2006-07-28
CN100345541C (zh) 2007-10-31
AU2003260620B2 (en) 2008-07-31
CA2491172C (fr) 2011-02-15
PT1515704E (pt) 2009-05-20
DK1515704T3 (da) 2009-07-20
AP2029A (en) 2009-08-24
CN1665491A (zh) 2005-09-07
MXPA05000086A (es) 2005-04-08
MA27262A1 (fr) 2005-03-01
KR20050023337A (ko) 2005-03-09
IS2679B (is) 2010-09-15
PL374377A1 (en) 2005-10-17
ECSP055570A (es) 2006-04-19
GEP20074212B (en) 2007-10-10
CA2491172A1 (fr) 2003-12-31
UA81121C2 (en) 2007-12-10
KR100722082B1 (ko) 2007-05-25
EA007571B1 (ru) 2006-12-29
AU2003260620A1 (en) 2004-01-06
IS7634A (is) 2005-01-07
RS50914B (sr) 2010-08-31
SI1515704T1 (sl) 2009-08-31
ATE429214T1 (de) 2009-05-15

Similar Documents

Publication Publication Date Title
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
NO2012006I1 (no) Telaprevir og enhver terapeutisk ekvivalent form derav som er beskyttet av basispatentet, slik som farmasøytisk akseptable salter og/eller solvater avtelaprevir eller solvater av slike salter
DK1448235T3 (da) Orale, farmaceutiske sammensætninger af 5,8,14-triaza-tetracyclo[10.3.1.0(2,11).0(4.9)]-hexadeca-2(11),3,5,7,9-pentaen med kontrolleret frigivelse
NO20080612L (no) Immunokonjugatpreparater
NO20030374D0 (no) Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
NO20020976L (no) Retarderte, orale, farmasöytiske administreringsformer
UY28001A1 (es) Derivados de azol-pirimidina condensados
NO20043367L (no) Oralt farmasoytisk preparat
NO20034660L (no) Spiropyrazolforbindelser, farmasoytiske preparater som omfatter en slik forbindelse, og anvendelse av forbindelsene for fremstilling av farmasoytiske preparater
MXPA05010174A (es) Derivados de indol e indolina sustituidos.
NO20052474L (no) Amort form av esomeprazolsalter
NO20065701L (no) Orodispersibel farmasoytisk sammensetning for oromukosal eller sublingval administrasjon av agomelatin
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
CY1109154T1 (el) Μικροκαψουλες για την καθυστερημενη και ελεγχομενη απελευθερωση της περινδοπριλης
DK1523473T3 (da) Indolinderivater substitueret i position 6, deres fremstilling og anvendelse som lægemiddel.
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
NO20064808L (no) Orale matrixformuleringer med licarbazepin
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application